Cargando…

Clinical Effectiveness of Tetracycline-Class Agents Based Regimens in Patients With Carbapenem-Resistant Acinetobacter baumannii Bacteremia: A Single-Center Retrospective Cohort Study

This study evaluated the clinical outcome of carbapenem-resistant Acinetobacter baumannii (CRAB) bacteremia and the clinical effectiveness of tetracyclines-based therapy. In a retrospective cohort study over 5 years period, 108 patients were included in the study. The overall 30-day mortality rate w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Si-Ho, Wi, Yu Mi, Peck, Kyong Ran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2023
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462474/ https://www.ncbi.nlm.nih.gov/pubmed/37644679 http://dx.doi.org/10.3346/jkms.2023.38.e263

Ejemplares similares

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2013)

1111. Lack of Effectiveness of Colistin in Carbapenem-Resistant Acinetobacter baumannii : A Retrospective Single Center Cohort Study
por: Kim, Si-Ho, et al.
Publicado: (2023)

Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019)

1855. Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia
por: Lee, Chan Mi, et al.
Publicado: (2022)

Is Aerosalization a Problem With Carbapenem-Resistant Acinetobacter baumannii in Thailand Hospital?
por: Apisarnthanarak, Anucha, et al.
Publicado: (2016)

Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients With Carbapenem-Resistant Acinetobacter baumannii Bacteremia
por: Son, Hyo-Ju, et al.
Publicado: (2020)

O047: The effect of active surveillance culture of carbapenem resistant Acinetobacter baumannii on the occurrence of carbapenem resistant Acinetobacter baumannii bacteremia in a single intensive care unit
por: Kim, G, et al.
Publicado: (2013)

Bacteremia Caused by Laribacter hongkongensis Misidentified as Acinetobacter lwoffii: Report of the First Case in Korea
por: Kim, Dae Sik, et al.
Publicado: (2011)

Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection
por: De Oliveira, David M. P., et al.
Publicado: (2022)

135. Clinical and Microbiologic Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia
por: Cho, Eunbeen, et al.
Publicado: (2019)

Carbapenem Breakpoints for Acinetobacter baumannii Group: Supporting Clinical Outcome Data from Patients with Bacteremia
por: Lee, Yi-Tzu, et al.
Publicado: (2016)

Laboratory to Clinical Investigation of Carbapenem Resistant Acinetobacter baumannii Outbreak in a General Hospital
por: Guo-xin, Mo, et al.
Publicado: (2014)

Efficacy of Fosfomycin-Containing Regimens for Treatment of Bacteremia Due to Pan-Drug Resistant Acinetobacter baumannii in Critically Ill Patients: A Case Series Study
por: Assimakopoulos, Stelios F., et al.
Publicado: (2023)

Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy
por: Kim, Youn Jeong, et al.
Publicado: (2012)

Evaluation of a Carbapenem-Saving Strategy Using Empirical Combination Regimen of Piperacillin-Tazobactam and Amikacin in Hemato-Oncology Patients
por: Ko, Jae-Hoon, et al.
Publicado: (2019)

Evolution of Acinetobacter baumannii in Clinical Bacteremia Patients
por: Li, Henan, et al.
Publicado: (2021)

Risk Factors for Occurrence and 30-Day Mortality for Carbapenem-Resistant Acinetobacter baumannii Bacteremia in an Intensive Care Unit
por: Kim, Song Yee, et al.
Publicado: (2012)

581. The Epidemiology of Imipenem-Resistant Acinetobacter baumannii Bacteremia in a Pediatric Intensive Care Unit and Carbapenem Use
por: Kim, Dongsub, et al.
Publicado: (2019)

Is Polymicrobial Bacteremia an Independent Risk Factor for Mortality in Acinetobacter baumannii Bacteremia?
por: Wang, Yung-Chih, et al.
Publicado: (2020)

Risk Factors for Mortality in Patients with Acinetobacter baumannii Bacteremia
por: Park, Se Yoon, et al.
Publicado: (2013)

Initial indicators for the prognosis of Acinetobacter Baumannii bacteremia in children
por: Hong, Yi, et al.
Publicado: (2023)

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii
por: Tiwari, Vishvanath, et al.
Publicado: (2014)

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital
por: Takagi, E.H., et al.
Publicado: (2009)

Fanny pack transmission of carbapenem-resistant Acinetobacter baumannii
por: DelleFave, Amber, et al.
Publicado: (2023)

Risk factors for progression to bacteremia among patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia in the Intensive Care Unit
por: Niu, Haiming, et al.
Publicado: (2023)

The Clinical Characteristics, Carbapenem Resistance, and Outcome of Acinetobacter Bacteremia According to Genospecies
por: Park, Kyung-Hwa, et al.
Publicado: (2013)

Correlation between Carbapenem Consumption and Carbapenems Susceptibility Profiles of Acinetobacter baumannii and Pseudomonas aeruginosa in an Academic Medical Center in Thailand
por: Paiboonvong, Taniya, et al.
Publicado: (2022)

Evaluation of outcome in critically ill patients with Acinetobacter baumannii bacteremia
por: Pratikaki, M, et al.
Publicado: (2005)

Risk Factors and Clinical Outcomes for Patients With Acinetobacter baumannii Bacteremia
por: Gu, Zhenyang, et al.
Publicado: (2016)

Risk Factors, Clinical Presentation, and Outcome of Acinetobacter baumannii Bacteremia
por: Ballouz, Tala, et al.
Publicado: (2017)

Tetracycline resistance mediated by tet efflux pumps in clinical isolates of Acinetobacter baumannii
por: Beheshti, Maryam, et al.
Publicado: (2020)

A case of disseminated intravascular coagulation secondary to Acinetobacter lwoffii and Acinetobacter baumannii bacteremia
por: Baldeo, Candice, et al.
Publicado: (2015)

Molecular Epidemiology of Carbapenem Non-Susceptible Acinetobacter baumannii in France
por: Jeannot, Katy, et al.
Publicado: (2014)

Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii
por: Pagano, Mariana, et al.
Publicado: (2016)

Seasonal Occurrence and Carbapenem Susceptibility of Bovine Acinetobacter baumannii in Germany
por: Klotz, Peter, et al.
Publicado: (2019)

Heterocyclic Diaryliodonium-Based Inhibitors of Carbapenem-Resistant Acinetobacter baumannii
por: Kumari, Pooja, et al.
Publicado: (2023)

Natural prognosis of carbapenem-resistant Acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: A retrospective multicenter study in Korea
por: Kim, Tark, et al.
Publicado: (2018)

Assessment of Effective Antimicrobial Regimens and Mortality-Related Risk Factors for Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
por: Gu, Shumin, et al.
Publicado: (2023)

Potential Synergy Activity of the Novel Ceragenin, CSA-13, against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Bacteremia Patients
por: Bozkurt-Guzel, Cagla, et al.
Publicado: (2014)

Enzyme Patterns and Factors Associated with Mortality among Patients with Carbapenem Resistant Acinetobacter Baumannii (CRAB) Bacteremia: Real World Evidence from a Tertiary Center in India
por: Prayag, Parikshit Shirish, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rt3g8rtp6nji93khi65f2bv9fp